Bioactive Compounds
-
N1441 Fraxinellone -
BA1842 AlamifovirSummary: Alamifovir (LY582563; MCC-478) is a purine nucleotide analog precursor that shows potent activity against wild-type and lamivudine-resistant hepatitis B virus. -
BA2996 UC-514321Summary: A selective TET1 inhibitor - BA1841 BA-53038BSummary: BA-53038B is a core protein alteration modulator (CpAM) that binds to the HAP pocket and regulates coat assembly.
- BA1840 InarigivirSummary: Inarigivir (ORI-9020; SB-9000) is a dinucleotide antiviral compound that significantly reduces DNA in transgenic mice expressing hepatitis B virus.
- BA1839 FNC-TPSummary: FNC-TP is the intracellular active form of FNC.
- C8447 TNF-α-IN-1
- BA1838 TorcitabineSummary: Torcitabine (2'-Deoxy-L-cytidine) is an antivirally active molecule.
- BA9746 KaolinSummary: Kaolin is used as a pharmaceutical excipient.
- BA4607 K34cSummary: K34c is a potent and selective antagonist.